RHYTHM PHARMACEUTICALS, INC. Defined Contribution Plan, Employer Matching Contribution, Percent of Match
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Match of 100.00% for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch · last filed 2024-02-29
- RHYTHM PHARMACEUTICALS, INC. defined contribution plan, employer matching contribution, percent of match for fiscal 2023 was 100.00%, a 0.00% change from fiscal 2022.
- RHYTHM PHARMACEUTICALS, INC. defined contribution plan, employer matching contribution, percent of match for fiscal 2022 was 100.00%, a 0.00% change from fiscal 2021.
- RHYTHM PHARMACEUTICALS, INC. defined contribution plan, employer matching contribution, percent of match for fiscal 2021 was 100.00%.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 12 month |
|---|---|
| 2023-12-31 | 100.00% 10-K · filed 2024-02-29 |
| 2022-12-31 | 100.00% 10-K · filed 2023-03-01 |
| 2021-12-31 | 100.00% 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |